← back to search

Frank A. Anania

United States Food and Drug Administration · US
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver physiology and pathology, Diet, Metabolism, and Disease, and Regulation of Appetite and Obesity.
h-index
48
citations
16,864
works
142
NIH funding
primary concept
Medicine
email

Recent publications

Blocking integrin α4β7-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis
Journal of Hepatology 2020cited by 79position: middledoi
Western diet‐induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis
The FASEB Journal 2020cited by 38position: middledoi
Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells
Journal of Biological Chemistry 2018cited by 75position: lastdoi
Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018cited by 36position: lastdoi
Dysregulation of junctional adhesion molecule‐A contributes to ethanol‐induced barrier disruption in intestinal epithelial cell monolayers
Physiological Reports 2017cited by 31position: lastdoi
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy 2016cited by 5,978position: middledoi
Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol
Gastroenterology 2016cited by 322position: lastdoi
C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis
Laboratory Investigation 2016cited by 41position: lastdoi
Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir: Figure 1.
Clinical Infectious Diseases 2015cited by 166position: middledoi
Adipocytokines and hepatic fibrosis
Trends in Endocrinology and Metabolism 2015cited by 132position: lastdoi
Low-Dose Cadmium Causes Metabolic and Genetic Dysregulation Associated With Fatty Liver Disease in Mice
Toxicological Sciences 2015cited by 126position: middledoi
Liver fibrosis occurs through dysregulation of MyD88‐dependent innate B‐cell activity
Hepatology 2015cited by 98position: middledoi
Randomised clinical trial: the beneficial effects of <scp>VSL</scp>#3 in obese children with non‐alcoholic steatohepatitis
Alimentary Pharmacology & Therapeutics 2014cited by 454position: middledoi
Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis
The Journal of Nutritional Biochemistry 2014cited by 80position: lastdoi
Adiponectin Agonist ADP355 Attenuates CCl4-Induced Liver Fibrosis in Mice
PLoS ONE 2014cited by 78position: lastdoi
Antagonistic interaction between Wnt and Notch activity modulates the regenerative capacity of a zebrafish fibrotic liver model
Hepatology 2014cited by 75position: middledoi
Mitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver
American Journal of Physiology-Gastrointestinal and Liver Physiology 2014cited by 40position: middledoi
Adiponectin modulates focal adhesion disassembly in activated hepatic stellate cells: implication for reversing hepatic fibrosis
The FASEB Journal 2014cited by 39position: lastdoi
Glial cell line-derived neurotrophic factor protects against high-fat diet-induced obesity
American Journal of Physiology-Gastrointestinal and Liver Physiology 2014cited by 39position: middledoi
The Role of Gastrointestinal Hormones in Hepatic Lipid Metabolism
Seminars in Liver Disease 2013cited by 71position: lastdoi
The Prevalence and Clinical Correlates of Nonalcoholic Fatty Liver Disease (NAFLD) in African Americans: The Multiethnic Study of Atherosclerosis (MESA)
Digestive Diseases and Sciences 2013cited by 52position: middledoi
Liver and diabetes. A vicious circle
Hepatology Research 2012cited by 206position: lastdoi
The Glucagon-Like Peptide-1 Receptor Agonist Exendin 4 Has a Protective Role in Ischemic Injury of Lean and Steatotic Liver by Inhibiting Cell Death and Stimulating Lipolysis
American Journal Of Pathology 2012cited by 58position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Pradeep Kumar · Emory University10 papers (2014–2020)Yunshan Liu · Emory University7 papers (2016–2020)Khalidur Rahman · Shahjalal University of Science and Technology5 papers (2014–2016)Reben Raeman · University of Pittsburgh4 papers (2018–2020)Daniel M. Chopyk · The Ohio State University Wexner Medical Center4 papers (2017–2020)Natalie Thorn · Emory University4 papers (2014–2016)Alton B. Farris · Emory University3 papers (2016–2020)Charles A. Parkos · Emory University3 papers (2016–2020)Jamie E. Mells · Emory University3 papers (2013–2014)Asma Nusrat · Michigan United3 papers (2016–2020)Chirayu Desai · Gujarat University3 papers (2016–2020)Allan D. Kirk · Duke University2 papers (2012–2014)Neeraj K. Saxena · Integral University2 papers (2014–2015)Ping Fu · Qingdao University2 papers (2014–2014)Rong Jiang · Chongqing University of Posts and Telecommunications2 papers (2012–2014)Carlos R. Abramowsky · Apple (Israel)2 papers (2012–2014)Nitika Gupta · Government Medical College and Hospital2 papers (2012–2014)Vasantha L. Kolachala · Emory University2 papers (2012–2014)Smita S. Iyer · University of Pittsburgh2 papers (2016–2020)Dean P. Jones · Brewster Place1 papers (2015–2015)